Cognex Corporation 10-K Summary: Fiscal Year Ended December 31, 2000
Business Context and Reporting Period
This Form 10-K covers the fiscal year ended December 31, 2000, for Cognex Corporation, a Massachusetts-based company incorporated in 1981. Cognex designs, develops, manufactures, and markets machine vision systems used to automate manufacturing processes. The company serves two primary customer types: Original Equipment Manufacturers (OEMs) and end users across industries such as semiconductor, electronics, automotive, and consumer products. Approximately 69% of revenue in 2000 was derived from international customers.
Key Financial Metrics
Specific consolidated revenue, net income, cash flow, and debt figures are not explicitly stated in the provided text, as the financial statements are incorporated by reference from the Annual Report to Stockholders (Exhibit 13). However, the following specific data points are available:
- Research, Development, and Engineering (R, D & E) Expenses: $33,341,000 in 2000, representing 13% of revenue.
- Backlog: $41,797,000 as of December 31, 2000.
- Allowance for Doubtful Accounts: Ended the year at $2,150,000.
- Reserve for Inventory Obsolescence: Ended the year at $3,709,000.
- Market Value: Aggregate market value of voting stock held by non-affiliates was $983,555,000 as of February 25, 2001.
- Outstanding Shares: 43,472,063 shares of common stock as of February 25, 2001.
Material Changes vs. Prior Period
- Backlog Growth: Backlog increased to $41,797,000 in 2000 from $36,788,000 in 1999.
- R&D Efficiency: R&D expenses as a percentage of revenue decreased to 13% in 2000, compared to 18% in 1999 and 20% in 1998, despite a nominal increase in dollar spend.
- Acquisitions: The company completed three acquisitions in 2000 to expand its end-user presence: assets of Komatsu Ltd. (Japan), Image Industries Ltd. (UK), and the web inspection business of Honeywell's Roibox subsidiary (Finland).
- Product Launches: Introduced the In-Sight product line (low-cost vision sensors) and Checkpoint II in 2000.
Outlook, Risks, and Contingencies
Management Strategy: Cognex intends to continue investing in direct sales and support globally while expanding in the end-user market. The company plans to retain all earnings to finance development and does not intend to pay cash dividends in the foreseeable future.
Legal Proceedings and Risks:
- Lemelson Litigation: The company is involved in a declaratory judgment action against the Lemelson Medical, Educational, & Research Foundation regarding patent validity. A decision is not expected for at least two years. Cognex disclaims liability for indemnification requests from customers regarding this matter.
- Patent Infringement Suits: Cognex filed lawsuits against National Instruments Corporation (May 2000) and Electro Scientific Industries, Inc. (February 2001) alleging patent infringement.
- Market Risks: The company faces exposure to foreign currency exchange rates (primarily Yen and Euro) and interest rate fluctuations. As of March 5, 2001, indicators suggested a strengthening dollar against the Yen and Euro, resulting in hypothetical gains on forward contracts.
Investor Verification Checklist
- Verify the specific consolidated revenue, net income, and cash flow figures in the Annual Report to Stockholders (Exhibit 13), as they are not detailed in this text.
- Review the status of the Lemelson patent litigation and potential indemnification liabilities from customers.
- Assess the integration progress and financial contribution of the three 2000 acquisitions (Komatsu, Image Industries, Roibox).
- Monitor the impact of foreign currency fluctuations on future earnings, given that 69% of revenue is international.
- Confirm the timeline and potential outcomes of the patent infringement lawsuits filed against National Instruments and ESI.